To compare the therapeutic efficacy of Mn‐N/C and MnCl2, we intratumorally injected MnCl2 (at 5 mg kg−1 as previously reported) and Mn‐N/C into CT26 tumor‐bearing mice. This evidence concerns the gene DDX53 and neoplasm.